US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Haloperidol Decanoate Injection

Reason Lack of Assurance of Sterility

Teva Pharmaceuticals USA NDC 00703-7121-03 D-0375-2021
Class II · Moderate risk Terminated

Leucovorin Calcium for Injection

Reason Lack of Assurance of Sterility

Teva Pharmaceuticals USA NDC 0703-5145-01 D-0374-2021
Class III · Low risk Terminated

Acyclovir Tablets

Reason Labeling: Incorrect or Missing Lot and/or Exp Date

Heritage Pharmaceuticals Inc NDC 23155-227-01 D-0367-2021
Class I · High risk Terminated

BD ChloraPrep Hi-Lite Orange 26 mL Applicator

Reason Defective Delivery System: An increase in complaints identified endcap being loose or falling off upon activation releasing glass shards containing the solution.

CareFusion 213, LLC NDC 54365-400-38 D-0373-2021
Class III · Low risk Terminated

Evrysdi

Reason Defective Container: complaints received regarding some incorrect press-in-bottle-adapters (PIBA), the incorrect PIBAs have a female instead of male fit so they cannot be used in combination with co-packed syringes.

Genentech Inc D-0357-2021
Class III · Low risk Terminated

Asenapine Sublingual Tablets

Reason Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent

SigmaPharm Laboratories LLC NDC 42794-017-10 D-0380-2021
Class III · Low risk Terminated

Asenapine Sublingual Tablets

Reason Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent

SigmaPharm Laboratories LLC NDC 42794-016-10 D-0379-2021
Class II · Moderate risk Terminated

Estradiol Transdermal System Delivers 0.0375 mg/day

Reason Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

Noven Pharmaceuticals Inc NDC 68968-3437-8 D-0337-2021
Class II · Moderate risk Terminated

Minivelle

Reason Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

Noven Pharmaceuticals Inc NDC 68968-6675-8 D-0336-2021
Class II · Moderate risk Terminated

Oxygen

Reason cGMP deviations

Grace Healthcare Medical, Inc D-0355-2021
Class III · Low risk Terminated

Dry Eye Test

Reason Subpotent Drug

Nomax Inc D-0387-2021
Class II · Moderate risk Terminated

Betadine

Reason Defective container; syringe content migrating past the seal of the plunger may cause a lack of assurance of sterility

Edge Pharma, LLC D-0335-2021
Class II · Moderate risk Terminated

Itraconazole Capsules

Reason Failed Dissolution Specifications

Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-282-30 D-0333-2021
Class II · Moderate risk Terminated

Riomet

Reason Microbial Contamination of Non-Sterile Product

Sun Pharmaceutical Industries INC NDC 10631-206-02 D-0334-2021
Class I · High risk Terminated

Thumbs up 7 Red 70K capsules

Reason Marketed Without An Approved NDA/ANDA: Products found to contain undeclared tadalafil and/ or sildenafil and vardenafil making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.

Ummzy, LLC D-0664-2021
Class I · High risk Terminated

Shogun-X capsules

Reason Marketed Without An Approved NDA/ANDA: Products found to contain undeclared tadalafil and/ or sildenafil and vardenafil making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.

Ummzy, LLC D-0663-2021
Class I · High risk Terminated

Krazy Night capsule

Reason Marketed Without An Approved NDA/ANDA: Products found to contain undeclared tadalafil and/ or sildenafil and vardenafil making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.

Ummzy, LLC D-0662-2021
Class II · Moderate risk Terminated

Antiseptic Hand Cleaner

Reason CGMP Deviations

Spartan Chemical Co Inc D-0361-2021
Class I · High risk Terminated

Lite'n Foamy Lemon Blossom Hand Sanitizer

Reason Microbial Contamination of Non-Sterile Products; lot tested positive for Bulkholderia multivorans

Spartan Chemical Co Inc D-0359-2021
Class III · Low risk Terminated

Lidocaine Ointment USP

Reason Failed Stability Specifications: product did not meet viscosity results.

Teligent Pharma, Inc. NDC 52565-008-14 D-0331-2021